RADHAKISHAN PHARMACEUTICALS
GEMITA GEMCITABINE INJECTION

GEMITA GEMCITABINE INJECTION

GEMITA GEMCITABINE INJECTION Specification

  • Dosage Form
  • Injection
  • Pacakaging (Quantity Per Box)
  • Single vial per box
  • Origin of Medicine
  • Imported
  • Salt Composition
  • Gemcitabine Hydrochloride
  • Indication
  • Treatment of ovarian, breast, pancreatic, and non-small cell lung cancer
  • Drug Type
  • Prescription only
  • Ingredients
  • Gemcitabine Hydrochloride
  • Physical Form
  • Liquid Injection
  • Function
  • Recommended For
  • Cancer treatment (including ovarian, breast, non-small cell lung, and pancreatic cancer)
  • Dosage
  • As prescribed by the oncologist; dosing varies based on type of cancer and patient condition
  • Dosage Guidelines
  • Administered intravenously under the supervision of a qualified physician
  • Suitable For
  • Adults
  • Quantity
  • 1000 mg per vial
  • Storage Instructions
  • Store below 25C, protect from light
  • Shelf Life
  • 2 years from the date of manufacture
  • Appearance
  • Clear, colorless to slightly yellow solution
  • Route of Administration
  • Intravenous (IV)
  • Registration Number
  • As per local authority approval
  • Warning
  • For hospital and oncology clinic use only
  • Reconstitution Instructions
  • Use sterile saline for reconstitution before IV infusion
  • Marketed By
  • Fresenius Kabi India Pvt. Ltd.
  • Strength
  • 1000 mg
  • Prescription Required
  • Yes
  • Brand Name
  • GEMITA
 

GEMITA GEMCITABINE INJECTION Trade Information

  • Packaging Details
  • PACK OF 1 VIAL
 

About GEMITA GEMCITABINE INJECTION

Specifications :-

  • Brand Name :- GEMITA
  • Content:-Gemcitabine
  • Strength:- 200 mg
  • Form:- injection
  • Packing:- Pack of 1 vial
  • Manufactured By :- Fresenius Kabi


Note :- GEMITA Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Othe...........



Powerful Cancer Therapy

GEMITA is formulated to deliver effective chemotherapy for adults diagnosed with ovarian, breast, pancreatic, or non-small cell lung cancer. Its trusted efficacy and broad indications make it a valuable option for oncologists seeking flexible and powerful cancer management strategies.


Strict Hospital Use and Safety

To ensure maximum safety and efficacy, GEMITA is administered exclusively in hospitals or oncology clinics, supervised by qualified healthcare professionals. Its intravenous route allows for controlled dosing tailored to individual patient needs, minimizing risk and maximizing therapeutic benefits.


Easy Preparation and Storage

Provided as a clear solution in single-vial packaging, GEMITA requires reconstitution with sterile saline before infusion. The injection must be stored below 25C and shielded from light, ensuring its stability and readiness for use throughout its two-year shelf life.

FAQs of GEMITA GEMCITABINE INJECTION:


Q: How should GEMITA Gemcitabine Injection be prepared for administration?

A: GEMITA should be reconstituted using sterile saline, following aseptic techniques, just before intravenous infusion as directed by hospital staff or oncology clinic personnel.

Q: What types of cancer are treated with GEMITA Gemcitabine Injection?

A: GEMITA is recommended for adults in the treatment of ovarian cancer, breast cancer, non-small cell lung cancer, and pancreatic cancer, as prescribed by an oncologist.

Q: When is GEMITA Gemcitabine Injection administered during cancer therapy?

A: Administration timing and dosing of GEMITA are determined by the treating oncologist, depending on cancer type, progression, and patient-specific treatment protocols.

Q: Where must GEMITA Gemcitabine Injection be administered?

A: GEMITA is intended for intravenous administration in hospital environments or specialized oncology clinics, under direct supervision of medical professionals.

Q: What is the process for storing GEMITA Gemcitabine Injection?

A: Store GEMITA below 25C, protected from light, and utilize the vial within its two-year shelf life to maintain product potency and safety.

Q: Is a prescription required to obtain GEMITA Gemcitabine Injection?

A: Yes, GEMITA is a prescription-only medication and must be dispensed and administered solely upon medical guidance from a licensed physician.

Q: What are the main benefits of GEMITA Gemcitabine Injection in cancer treatment?

A: GEMITA offers targeted anti-cancer effects, flexible dosing tailored by oncologists, and proven efficacy across multiple cancer types, contributing to improved treatment outcomes under medical supervision.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Drugs & Medications Category

VELASOF SOFOSBUVIR AND VELPATSAVIR TABLETS

VELASOF SOFOSBUVIR AND VELPATSAVIR TABLETS

Minimum Order Quantity : 1 Box

Dosage Guidelines : Take one tablet orally once daily with or without food

Dosage : As directed by physician

Storage Instructions : Store below 30C, protect from moisture and light

Origin of Medicine : India

Physical Form : Tablets

RESOF TOTAL SOFOSBUVIR 400MG AND VELPATASVIR

RESOF TOTAL SOFOSBUVIR 400MG AND VELPATASVIR

Dosage Guidelines : One tablet daily, or as prescribed

Dosage : As directed by the physician

Storage Instructions : Store below 30C, protect from moisture and light

Origin of Medicine : India

Physical Form : Tablets

PANGRAF TACROLIMUS CAPSULES

PANGRAF TACROLIMUS CAPSULES

Dosage Guidelines : Take as directed by your transplant specialist

Dosage : As prescribed by physician

Storage Instructions : Store below 25C in a dry place, protect from light

Origin of Medicine : Allopathic

Physical Form : Capsules

DACLACURE  DACLATASVIR DIHYDROCHLORIDE TABLETS

DACLACURE DACLATASVIR DIHYDROCHLORIDE TABLETS

Dosage Guidelines : As directed by the physician; generally one tablet daily.

Dosage : 60 mg

Storage Instructions : Store in a cool, dry place below 30C. Protect from light and moisture.

Origin of Medicine : Allopathic

Physical Form : Tablets



Back to top